Sumitomo Pharma Co., Ltd.
SMDPY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $260,622 | $20,453,000 | $23,116,000 | $85,393,000 |
| Short-Term Investments | $0 | $0 | $16,840,000 | $0 |
| Receivables | $861,719 | $83,380,000 | $74,840,000 | $94,323,000 |
| Inventory | $560,348 | $89,751,000 | $94,222,000 | $107,426,000 |
| Other Curr. Assets | $153,028 | $63,134,000 | $44,150,000 | $46,546,000 |
| Total Curr. Assets | $1,835,718 | $256,718,000 | $253,168,000 | $333,688,000 |
| Property Plant & Equip (Net) | $304,290 | $46,103,000 | $46,648,000 | $52,613,000 |
| Goodwill | $1,330,243 | $191,175,000 | $197,406,000 | $208,787,000 |
| Intangibles | $1,127,467 | $164,726,000 | $172,509,000 | $194,484,000 |
| Long-Term Investments | $561,222 | $7,346,000 | $72,339,000 | $0 |
| Tax Assets | $3,142 | $0 | $534,000 | $0 |
| Other NC Assets | $108,623 | $67,265,000 | $0 | $62,543,000 |
| Total NC Assets | $3,434,987 | $476,615,000 | $489,436,000 | $518,427,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,270,705 | $733,333,000 | $742,604,000 | $852,115,000 |
| Liabilities | – | – | – | – |
| Payables | $284,701 | $39,308,000 | $38,544,000 | $49,278,000 |
| Short-Term Debt | $27,085 | $50,188,000 | $46,440,000 | $254,960,000 |
| Tax Payable | $0 | $0 | $1,577,000 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,035,874 | $142,191,000 | $154,042,000 | $195,101,000 |
| Total Curr. Liab. | $1,347,659 | $231,687,000 | $240,603,000 | $499,339,000 |
| LT Debt | $1,752,717 | $259,057,000 | $258,982,000 | $119,463,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $96,144 | $0 | $26,550,000 | $0 |
| Other NC Liab. | $275,844 | $66,356,000 | $46,990,000 | $67,198,000 |
| Total NC Liab. | $2,124,705 | $325,413,000 | $332,522,000 | $186,661,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,472,363 | $557,100,000 | $573,125,000 | $686,000,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $151,674 | $22,400,000 | $22,400,000 | $22,400,000 |
| Retained Earnings | $998,856 | $57,924,000 | $46,784,000 | $41,601,000 |
| AOCI | $652,429 | $96,591,000 | $100,977,000 | $102,796,000 |
| Other Equity | -$4,618 | -$682,000 | -$682,000 | -$682,000 |
| Total Equity | $1,798,341 | $176,233,000 | $169,479,000 | $166,115,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,270,705 | $733,333,000 | $742,604,000 | $852,115,000 |
| Net Debt | $1,519,179 | $288,792,000 | $282,306,000 | $289,030,000 |